Ver Investigador - - Prisma - Unidad de Bibliometría

Teresa Caballero Velazquez

Investiga en

Tipo Año Título Fuente
Artículo2024 Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions BRITISH JOURNAL OF CANCER
Corrección2024 Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring (Front. Immunol., (2024), 14, 1280580, 10.3389/fimmu.2023.1280580) FRONTIERS IN IMMUNOLOGY
Revisión2024 Hematological Neoplasms with Eosinophilia CANCERS
Letter2024 Monocytosis as prognostic factor for chronic graft versus host disease BONE MARROW TRANSPLANTATION
Artículo2024 Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features CELLULAR ONCOLOGY
Artículo2023 Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring FRONTIERS IN IMMUNOLOGY
Artículo2023 Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies FRONTIERS IN IMMUNOLOGY
Artículo2023 Prognostic value of measurable residual disease in patients with AML undergoing HSCT: a multicenter study CANCERS
Artículo2023 Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice Journal of personalized medicine
Artículo2023 Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials. CLINICAL CANCER RESEARCH
Artículo2022 Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib. Scientific reports
Letter2022 Multiple erythrophagocytosis by erythroid blasts in acute myeloid leukemia with BCR-ABL1 ANNALS OF HEMATOLOGY
Artículo2022 Phase I/II clinical trials of donor-derived purified regulatory T cells for the treatment of steroid-refractory chronic graft versus host disease BLOOD
Artículo2022 Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment Transplantation and Cellular Therapy
Artículo2022 The incidental detection of clonal haemopoiesis of indeterminate potential with del(5q) BRITISH JOURNAL OF HAEMATOLOGY
Artículo2021 Auer rod-like inclusions in cerebrospinal fluid in accelerated phase chronic lymphocytic leukaemia BRITISH JOURNAL OF HAEMATOLOGY
Artículo2021 Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease. BONE MARROW TRANSPLANTATION
Artículo2021 High-dimensional analysis of single-cell flow cytometry data predicts relapse in childhood acute lymphoblastic leukaemia CANCERS
Artículo2021 Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia LEUKEMIA
Artículo2020 ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype CANCER MEDICINE
Artículo2020 Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation BONE MARROW TRANSPLANTATION
Artículo2020 Eosinophils engulfing platelets and with ring-shaped nuclei in nivolumab-associated eosinophilia BRITISH JOURNAL OF HAEMATOLOGY
Artículo2020 Polyphenolic extract (PE) from olive oil exerts a potent immunomodulatory effect and prevents graft-versus-host disease in a mouse model BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2020 Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study BONE MARROW TRANSPLANTATION
Artículo2019 Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019 Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2019 Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms CLINICAL CANCER RESEARCH
Artículo2018 Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy MODERN PATHOLOGY
Resumen congreso2018 European Myeloma Network phase I trial on RIC allogeneic transplantation: an optimized program for high risk relapsed myeloma patients BONE MARROW TRANSPLANTATION
Artículo2018 Genotoxicity of tetrahydrofolic acid to hematopoietic stem and progenitor cells CELL DEATH AND DIFFERENTIATION
Letter2018 KIT D816V-chronic myelomonocytic leukemia progressing to KIT D816V+associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation ANNALS OF HEMATOLOGY
Artículo2018 MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3 ' region mRNA expression EUROPEAN JOURNAL OF HAEMATOLOGY
Resumen congreso2018 Pre-clinical trial to evaluate the effectiveness of ixazomib as a prophylaxis of sickness disease against guest (chronic eich) in a murine model HAEMATOLOGICA
Resumen congreso2018 Pre-Clinical Trial to Evaluate the Efficacy of Delayed Administration of Ixazomib in the Prophylaxis of Chronic Graft-Versus-Host Disease BLOOD
Resumen congreso2018 Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia BLOOD
Artículo2018 Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting MEDICAL ONCOLOGY
Artículo2018 Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: "Doublet Technology" FRONTIERS IN IMMUNOLOGY
Artículo2017 Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo INTERNATIONAL JOURNAL OF CANCER
Artículo2017 RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes HEMATOLOGICAL ONCOLOGY
Resumen congreso2017 Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study BLOOD
Resumen congreso2017 Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm BLOOD
Resumen congreso2017 Xenografts of blasts originating from patients with acute myeloblastic leukemia in immunosuppressed mice: clinical implications potentials HAEMATOLOGICA
Artículo2016 Caspase-8 inhibition represses initial human monocyte activation in septic shock model ONCOTARGET
Editorial2016 Haemophagocytosis by neoplastic cells in aleukaemic variant of mast cell leukaemia BRITISH JOURNAL OF HAEMATOLOGY
Artículo2016 Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial CLINICAL CANCER RESEARCH
Artículo2016 Leukaemic blast cannibalism in acute megakaryoblastic leukaemia with myeloid sarcoma BRITISH JOURNAL OF HAEMATOLOGY
Artículo2016 NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
Artículo2016 Sensitivity of hematopoietic stem cells to mitochondrial dysfunction by SdhD gene deletion CELL DEATH & DISEASE
Artículo2016 Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm DIAGNOSTIC CYTOPATHOLOGY
Resumen congreso2016 Survival and long-term complications of receptors of hematopoietic progenitor transplantation HAEMATOLOGICA
Artículo2015 GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT BONE MARROW TRANSPLANTATION
Artículo2015 Human Bone Marrow Stromal Cells Differentiate Into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice Cell Transplantation
Resumen congreso2015 IMPLICATIONES OF THE ADVERSE KARYOTYPE IN PATIENTS WITH MYELODYSPPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA. EXPERIENCE OF A CENTRE HAEMATOLOGICA
Artículo2015 Multiple Pseudo-Chediak-Higashi Inclusions Associated with MYC Deletion in a Patient with Acute Myeloid Leukemia ACTA HAEMATOLOGICA
Artículo2015 Myelomatous plasma cells display an aberrant gene expression pattern similar to that observed in normal memory B cells American Journal of Cancer Research
Artículo2015 The CD27(+) memory B cells display changes in the gene expression pattern in elderly individuals IMMUNOLOGY
Artículo2014 Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma BLOOD
Artículo2014 Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2013 Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis Leukemia Research Reports
Resumen congreso2013 Memory B Cells Display Changes In The Expression Pattern Of Genes Related To Cell Survival In Elderly Individuals BLOOD
Resumen congreso2013 Myelomatous Plasma Cells Display An Intermediate Gene Expression Pattern Between a Normal Plasma Cell and a Memory B Cell BLOOD
Artículo2013 Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients BRITISH JOURNAL OF HAEMATOLOGY
Artículo2013 Uptake and delivery of antigens by mesenchymal stromal cells CYTOTHERAPY
Artículo2012 Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment LEUKEMIA RESEARCH
Artículo2012 Evaluation of prognostic factors among patients with chronic graft-versus-host disease HAEMATOLOGICA
Artículo2012 The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation HAEMATOLOGICA
Artículo2011 Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens LEUKEMIA RESEARCH
Letter2011 Effect of vitamin D treatment in chronic GVHD BONE MARROW TRANSPLANTATION
Artículo2011 Helicobacter pylori Infection and Graft-versus-Host Disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2011 Limbus Damage in Ocular Graft-versus-Host Disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2010 Chronic graft-versus-host disease METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
Artículo2010 Diagnosis and management of immunodeficiencies in adults by allergologists JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY
Artículo2010 Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting BLOOD
Letter2010 Liver function tests and absolute lymphocyte count at day+100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant AMERICAN JOURNAL OF HEMATOLOGY
Artículo2009 Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Artículo2009 Treatment with bortezomib of human CD4(+) T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population HAEMATOLOGICA
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado